Sign in / Join Now
ETFs & Funds
Alan Robert Ross
PCYC's Imbruvica Gets Approved By FDA With Less Data & More Serious Side-Effects Than PV-10 $
Add a reply...
Latest StockTalks »
people get PVCT breaking news and analysis by email alert.
Get email alerts on PVCT »
Provectus Biopharmaceuticals, Inc.
Get latest price
From other sites
Provectus Biopharmaceuticals, Inc. Announces Pricing Of Public Offering To Raise $6 Million
at TheStreet (Thu, 9:25AM)
Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering Of Preferred Stock And Warrants
at TheStreet (Wed, 4:05PM)
Provectus Biopharmaceuticals, Inc. Receives Patent From USPTO Related To Rose Bengal Analogs
at TheStreet (Tue, 6:00AM)
Provectus Biopharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results
at TheStreet (Aug 9, 2016)
Provectus Biopharmaceuticals Announces Poster Presentation On PV-10 For Melanoma At European Society For Medical Oncology 2016 Congress
at TheStreet (Aug 1, 2016)